Abstract Damnacanthal and nordamnacanthal, two naturally occurring 9,10-anthraquinones, and their analogues were synthesized. Cytotoxic activity against five cancer cell lines was evaluated using MTT assay. 2-Bromomethyl-1,3-dimethoxyanthraquinone was found to display the highest activity against all cell lines with IC 50 range of 2-8 lM. Structureactivity relationship (SAR) assessment was considered to rationalise the cytotoxic effect. Bromomethyl group at position C-2 of the anthraquinone was found to be important in exerting cytotoxic activity of this class of compounds. The presence of the flanking methoxyl or hydroxyl groups at C-1 and C-3 also contributes to this activity. Finally, the antioxidant effect of these compounds was evaluated. MTT assay was used to measure the cytotoxicity against different cancer cell lines. Antioxidant activity was measured by FTC and TBA methods. Only two anthraquinones, damnacanthal and nordamnacanthal, were found to be antioxidative.
Introduction
Anthraquinones continue to attract interest among researchers due to its diverse potential pharmacological uses. 9,10-Anthraquinone derivatives are known to exhibit a quite potent anticancer activity (Jin et al., 2001; Zagotto et al., 2000) . Anthraquinones are well known for their antioxidant property (Huang et al., 1995; Yen et al., 2000) , and have also been reported to exhibit diverse bioactivities including hypotensive, antimicrobial, antiplasmodial, antitumor and cytotoxic effects (Chang et al., 1982; Johnson et al., 1997; Mishra and Gupta, 1982) . Unfortunately, anthraquinones are also reported to display undesirable side effects, such as cardiotoxicity (Cardia et al., 2001) .
In our previous efforts to discover new bioactive constituents from our plant resources, we isolated a new 2-formyl-1-hydroxyanthraquinone along with ten other known 9,10-anthraquinones, including damnacanthal and nordamnacanthal (Ismail et al., 1997) . Both damnacanthal and nordamnacanthal exhibited strong and selective cytotoxic activity against CEM-SS and MCF-7 as compared to HeLa cell lines . In order to further understand the role of these anthraquinones in their mechanism leading to cell death of anti-proliferative activity towards cancer cell lines, a programme to synthesise these compounds along with their analogues was conducted with the aim of selecting the best candidate for its further larger scale preparation and biological evaluation. We herein report the synthesis of a number of substituted simple 9,10-anthraquinone analogues, followed by the evaluation of their cytotoxic and antioxidant activities, and finally to assess their structure-activity relationship.
Results and discussion
The structure of anthraquinone analogues is represented in Fig. 1 . Friedel-Crafts condensation was selected as method of choice for the preparation of the anthraquinone skeleton due to the simplicity of the reaction and less demanding conditions (Wei et al., 2000; Werner et al., 1997; Zhang et al., 1996) . Phthalic anhydride and suitable substituted benzenes were used as the starting materials for the desired anthraquinones (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . Methylated hydroxyanthraquinones 11-14 as well as 17-18, were prepared from the respective 5 and 8-10 using CH 3 I in the presence of NaH or (CH 3 ) 2 SO 4 in the presence of anhydrous K 2 CO 3 (Enger and Iyenrar, 1998; Roberts et al., 1997) , in appropriate reaction conditions. Acetylation of hydroxyanthraquinones was accomplished by treating the respective starting materials with Ac 2 O with K 2 CO 3 used as base. Compound 10 with free unprotected hydroxyl was converted to the unexpected 15 in good yield, upon bromination using N-bromosuccinimide in the presence of benzoyl peroxide. However, upon bromination using the same reagent, compounds 16 and 17 gave the expected bromomethyl and dibromomethyl derivatives (19-21) (Cambie et al., 1992) in good yields. Compound 20 was further converted to 22 by demethylation using anhydrous aluminium chloride (Zacharie et al., 1997) .
The bromomethyl derivatives, 19 and 20 were successfully converted to the respective ethoxymethyl derivatives 23 and 24 by treating them with ethanol in the presence of aqueous sodium hydroxide. 2-Formylanthraquinones, 26-28 were obtained when the respective ethoxymethyl derivatives 23-25 were brominated with N-bromosuccinimide in the presence of benzoyl peroxide followed by hydrolysis with aqueous acetic acid .
Fig. 1 Structure of synthesized anthraquinones
Compound 28 was converted to 29 by demethylation using anhydrous aluminium chloride. The anthraquinone analogues were evaluated for their cytotoxic activity against five different cell lines: breast cancer (MCF7), human uterine sarcoma (MES-SA), multidrug-resistant variant human uterine sarcoma (MES-SA/ DX5), prostate cancer (DU145) and lung cancer (H460). The highest concentration of the compound used for the MTT assay was 100 lM with the lowest 0.1 lM using 10-fold serial dilution. Table 1 shows the overall results of cytotoxic activity of the analogues.
2-Bromomethyl-1,3-dimethoxyanthraquinone 20 was found to be the most cytotoxic compound against all cell lines tested. The IC 50 values for this compound range between 2 and 8 lM. However, this compound did not show any selectivity against any particular cell line. Additional bromine in dibromo derivative 21 seemed to decrease the cytotoxicity of 20 in all the cancer cell lines.
This may be related to the increase in the calculated lipophilicity (ALOGPs) with the predicted value of 4.44. The addition of the second bromo atom in the bromoalkyl group could result in the increase in the hydrophobic character, which is crucial in determining the capability of the compound to cross the cell membranes. Another derivative of bromomethylanthraquinone 19 exhibited strong cytotoxicity against MCF7 (IC 50 : 6 lM) and DU145 (IC 50 : 5 lM) cell lines. On the other hand, compound 22, which also bears bromomethyl group at position-2 but with hydroxyl group at position-1, showed a degree of selectivity against human uterine sarcoma (MES-SA) cell line with IC 50 value of 4 lM. However, both the compounds 19 and 22 failed to match the activity of compound 20. It is noteworthy that the 2-formyl analogues of these compounds also showed some degree of selectivity towards cancer cell lines tested Further inspection on the solubility (ALOGpS) of compounds 20, 21, 19 and 22 demonstrated that they are less sufficient for fast absorption due to the lower (calculated) solubility. According to the study on the rate-limiting steps of human oral absorption of 238 drugs, the absorption is usually very low if the calculated solubility is less than 0.00001 mg/L (Zhao et al., 2002) . Therefore, it is critical to improve the solubility of these compounds to permit dissolution and absorption in the future studies. Compound 22 showed promising results by displaying only moderate activity against other cell lines and could be a potential candidate for further drug development. Other compounds including 14, 21, 28 and 29 also showed selectivity against MES-SA cell line. Damnacanthal (26), although exhibited only moderate activity against DU145 and H460, displayed some selectivity against MCF7 with IC 50 value 11 lM.
The overall results indicated that anthraquinones containing bromomethyl group at C-2 with dimethoxy or methoxy and acetoxy at C-1 and C-3, respectively, (19 and 20) markedly increased cytotoxic activity while the presence of hydroxyl at C-1 instead of methoxy reduced the cytotoxicity but increased the selectivity (22). The presence of a formyl group at C-2 with methoxy at C-1 and hydroxy at C-3 also caused significant cytotoxicity (26 and 27) . Comprehensively, the theoretical study of these compounds showed that they fulfilled Lipinski rule-of-5 and drug-like properties. Another important physicochemical criterion is the polar surface area (PSA), which is based on the summation of tabulated surface contributions of polar fragments. In this experiment, we calculated the polar surface area of the compounds using the topological PSA (TPSA) procedure (see Table 2 ). All the compounds were generally within the desired limits of TPSA in the range of 50-100 Å 2 , suggesting a potentially good intestinal absorption, blood-brain barrier penetration and permeability across cell membranes. Chem Res (2013 ) 22:2093 -2104 2095 Antioxidant activity of the anthraquinones was measured using ferric thiocyanate (FTC) and thiobarbituric acid (TBA) methods. The FTC method measures the amount of peroxide in the initial stage of lipid peroxidation. Low absorbance value in the FTC method indicates high level of antioxidant activity. Only three anthraquinones, damnacanthal (26), nordamnacanthal (29) and commercial alizarin displayed stronger antioxidant activity than vitamin E, although these compounds showed lower activity than butylated hydroxy toluene (BHT). Alizarin exhibited stronger activity than compound 26 and 29 (Fig. 2) . All other anthraquinones were found to be inactive.
During the oxidation process, peroxide is gradually decomposed to lower molecular compounds and the relative concentrations are measured using TBA method. Figure 3 shows the absorbance value of active anthraquinones and the standards. The absorbance value was measured on the final day (8th day) of FTC assay. The results were found to be consistent with the results of the assay using FTC method. Anthraquinones containing ortho-dihydroxy moiety exhibited antioxidant activity, e.g. alizarin. The presence of formyl group next to a hydroxyl in anthraquinone derivative also plays an important role in their antioxidant activity (26 and 29).
Experimental
Melting points were determined on a hot stage melting point apparatus XSP-12 model 500X and are uncorrected. UV spectra were recorded on a CARY 100 Conc UV-Visible spectrophotometer in CHCl 3 or MeOH. IR spectra were recorded on a Perkin Elmer RXI FT-IR spectrometer as KBr disc. Mass spectra were measured on Finnigan Mat SSQ 710 spectrometer with ionization induced by electron impact at 70 eV. NMR spectra were recorded in CDCl 3 or DMSO-d 6 using Varian 500 MHz NMR spectrometer. Column chromatography was performed on Silica gel 60 Merck 9385 (230-400 mesh ASTM).
General procedure for anthraquinone synthesis
A mixture of anhydrous aluminium chloride (60 g, 450 mmol) and sodium chloride (12 g, 205 mmol) was heated until it completely melted (external temperature, 125-130°C). Phthalic anhydride (6.7 g, 45 mmol) and benzene derivative (41 mmol) were mixed well and slowly introduced into the melt of aluminium chloride and sodium chloride. The mixture was heated with stirring at 165-170°C for 45 min. After cooling, the reaction mixture was decomposed by adding a mixture of ice and hydrochloric acid. The acidic mixture was then briefly heated under reflux and filtered after cooling. The crude residue was extracted with ethyl acetate and the compounds were purified from ethyl acetate extract by using column chromatography.
3-Bromo-1-hydroxyanthraquinone (1), 4-bromo-1-hydroxyanthraquinone (2), 3-bromo-2-hydroxyanthraquinone (3), 1-hydroxyanthraquinone (4) and 2-hydroxyanthraquinone (5)
Phthalic anhydride (6.7 g, 45 mmol) and 4-bromophenol (7.05 g, 41 mmol) were reacted according to the general procedure to produce 1 (2.97 g, 24 %), 2 (1.36 g, 11 %), 3 (0.99 g, 8 %), 4 (0.37 g, 4 %) and 5 (0.28 g, 3 %) with the total yield of 50 %. 13 C NMR (DMSO-d 6 ) d 182.8 (C-10), 181.2 (C-9), 160.4 (C-2), 135.4 (C-6), 135.0 (C-7), 134.8 (C-13), 133.7 (C-11), 133.6 (C-12), 132.9 (C-1), 127.4 (C-5 & C-8), 126.6 (C-14), 117.5 (C-3), 113.5 (C-4) 
1-Bromo-3-hydroxyanthraquinone (6)
Reaction between phthalic anhydride (6.7 g, 45 mmol) and 3-bromophenol (7.05 g, 41 mmol) gave four products including 1 (3.96 g, 32 %), 2 (0.12 g, 1 %), 4 (0.46 g, 5 %) and 6 (1.36 g, 11 %). The total yield was 49 %. 
1,3-Dihydroxyanthraquinone or xanthopurpurin (7)
When phthalic anhydride (6.7 g, 45 mmol) and resorcinol (4.51 g, 41 mmol) were used as starting material, two products 7 (0.98 g, 11 %) and 3,3-di(2 0 ,4 0 -dihydroxyphenyl)phthalide (2.29 g, 31 %) were found with total yield of 42 %. 
1,4-Dihydroxyanthraquinone or quinizarin (8)
Reaction between phthalic anhydride (6.7 g, 45 mmol) and hydroquinone (4.51 g, 41 mmol) produced 8 (4.33 g) with 44 % yield. 
1-Hydroxy-4-methylanthraquinone (9)
Reaction between phthalic anhydride (6.7 g, 45 mmol) and p-cresol (4.43 g, 41 mmol) gave compound 9 (4.39 g, 45 %). 
1,3-Dihydroxy-2-methylanthraquinone or rubiadin (10)
Reaction between phthalic anhydride (6.7 g, 45 mmol) and 2-methylresorcinol (5.08 g, 41 mmol) produced 10 (4.16 g) with 40 % yield. 
2-Methoxyanthraquinone (11)
Sodium hydride (39 mg, 1.6 mmol) and 2 molar methyl iodide solution in tert-butyl methyl ether (4 mL, 8 mmol) were added successively into the solution of compound 5 (179 mg, 0.8 mmol) in dimethylformamide (10 mL) and the reaction mixture was stirred at room temperature for 20 h. The reaction mixture was poured into crushed ice and the product 11 (171 mg, 90 %) was purified by crystallization. 
1-Hydroxy-4-methoxyanthraquinone (12) and 1,4-dimethoxyanthraquinone (13)
Dimethyl sulphate (4 mL, 42.3 mmol) was added slowly into the mixture of 8 (96 mg, 0.4 mmol) and anhydrous potassium carbonate (1.6 g, 11.8 mmol) in dry acetone (40 mL) and the reaction mixture was refluxed for 6 h. The reaction mixture was then poured into crushed ice and filtered. The product 12 (62 mg, 60 %) and 13 (21 mg, 20 %) were purified by column chromatography. 
1-Methoxy-4-methylanthraquinone (14)
Compound 14 (101 mg, 100 %) was formed when 9 (95 mg, 0.4 mmol) was methylated with dimethyl sulphate (2 mL, 21.2 mmol) and anhydrous potassium carbonate (0.8 g, 5.9 mmol). The reaction time was 22 h at reflux condition. (27), 223 (80), 209 (35), 195 (14) , 178 (29), 165 (64), 152 (60), 126 (5), 77 (6), 63 (5).

4-Bromo-1,3-dihydroxy-2-methylanthraquinone (15)
A mixture of compound 10 (203 mg, 0.8 mmol), N-bromosuccinimide (370 mg, 2.08 mmol) and benzoyl peroxide (20 mg) in carbon tetrachloride (50 mL) was refluxed for 24 h. The solvent was evaporated and the product was washed with warm water and then dissolved in a small amount of acetone. The solution was poured into crushed ice and the precipitates were collected by filtration. Column chromatography was used to purify the product 15 (159 mg, 60 %). 
4-
3-Acetoxy-1-hydroxy-2-methylanthraquinone (16)
Acetic anhydride (1.4 ml, 14.6 mmol) was added dropwise into the mixture of anhydrous potassium carbonate (0.8 g, 5.84 mmol) and compound 10 (370 mg, 1.46 mmol) in dry acetone (25 mL) and the reaction mixture was stirred for 20 h at room temperature. The mixture was then poured into crushed ice and filtered. The product 16 (431 mg, 100 %) was purified by crystallization. 3-Acetoxy-1-methoxy-2-methylanthraquinone (17) Compound 17 (451 mg, 100 %) was formed when 16 (431 mg, 1.46 mmol) was methylated with dimethyl sulphate (4.9 ml, 51.1 mmol) and anhydrous potassium carbonate (2.01 g, 14.6 mmol) in dry acetone at reflux condition for 22 h. 
1,3-Dimethoxy-2-methylanthraquinone (18)
Compound 10 (400 mg, 1.57 mmol) was methylated with dimethyl sulphate (10.4 mL, 110 mmol) in the presence of anhydrous potassium carbonate (4.26 g, 31.4 mmol) at reflux condition for 22 h to form 18 (444 mg) as 100 % product. 236 (42), 221 (30), 193 (31), 181 (39), 165 (44), 152 (44), 139 (24), 111 (10), 83 (14) , 57 (10).
3-Acetoxy-2-bromomethyl-1-methoxyanthraquinone (19)
Compound 19 (376 mg, 100 %) was formed when compound 17 (300 mg, 0.97 mmol) was brominated with N-bromosuccinimide (329 mg, 1.84 mmol) and benzoyl peroxide (30 mg) in carbon tetrachloride at reflux condition for 24 h. ? , 2), 360 (M ? , 3), 281 (100), 267 (6), 236 (7), 223 (4), 181 (5), 165 (7), 152 (9), 139 (6), 76 (2).
2-Dibromomethyl-1,3-dimethoxyanthraquinone (21) Yellow crystals; mp 145-146°C; UV (CHCl 3 ) k max 369, 339, 280, 245 nm; IR (KBr disc) m 3042, 2933 , 1674 , 1577 (C = C, aromatic), 1331, 1287, 1130, 984, 712 31-8.26 (2H, m, H-5 & H-8), 7.85-7.76 (3H, m, H-4, H-6 & H- (12), 194 (13), 165 (16), 151 (15) , 138 (9), 76 (4).
2-Bromomethyl-1-hydroxy-3-methoxyanthraquinone (22)
Anhydrous aluminium chloride (167 mg, 1.12 mmol) was introduced into the solution of 20 (50 mg, 0.14 mmol) in dichloromethane (30 mL). Pyridine (0.04 mL, 0.56 mmol) was then added dropwise and the reaction mixture was refluxed for 24 h, acidified with dilute hydrochloric acid and extracted with ethyl acetate. The product 22 (33 mg, 68 %) was purified by column chromatography. 
2-Ethoxymethyl-3-hydroxy-1-methoxyanthraquinone (23)
Compound 19 (376 mg, 0.97 mmol), ethanol (37 mL) and 10 % aq. NaOH (5 mL) were taken together and stirred the solution for 24 h at room temperature. Addition of water (125 mL) and 10 % aq. HCl (6 mL) into the reaction mixture gave precipitates which were filtered and dried. The compound 23 (227 mg, 75 %) was finally purified by column chromatography. 
2-Ethoxymethyl
1,3-Dimethoxy-2-ethoxymethylanthraquinone (24)
Compound 24 (240 mg, 76 %) was formed when 20 (349 mg, 0.97 mmol) was reacted with ethanol (37 mL) and 10 % aq. NaOH (5 mL) at room temperature. Cytotoxic assay
Cell culture
The cancer cell lines were cultured in incubator with a 95 % humidified atmosphere containing 5 % CO 2 at 37°C. Once cells reached 80 % confluency, the medium was removed and 1 mL of trypsin-EDTA (concentrated) was added to detach the cells from the flask. The cells were collected in a fresh medium as subculture. This subculturing procedure was done approximately every 3-4 days at a density of 0.64 9 10 6 cells/ml in a 25 cm 2 flask. Cell cultures were routinely checked for mycoplasmal contamination.
Assay procedure
Rapidly growing cells were harvested by mild trypsinization to detach them from the substratum of the culture flask and fresh medium was added to prepare suspensions of single cell. The cells were counted using the improved Newbauer haemacytometer. 4,000-5,000 cells in 180 lL media were transferred into each well of 96-well plates. The microtiter plates were incubated overnight for cell attachment. Subsequently, each well was added with 20 lL of sample solution diluted in RPMI 1640 medium. Final concentrations 0.1-100 lM for compounds were used with tenfold serial dilution. The DMSO concentration was maintained at 0.1 %. 20 ll of fresh medium alone was added to control wells to make the final volume of 200 ll and medium alone (without cells and sample) was used as blank. Each concentration of the sample was assayed in quadruplicate and the plate was incubated for 96 h. The fraction of surviving cells was determined relative to the untreated cell population by the colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) method (Mosmann, 1983) . 50 ll of 2 mg/mL MTT was added to each well after discarding the supernatant and the plates were incubated for 4 h at 37°C in 95 % air and 5 % CO 2 for the formation of insoluble purple formazan. Then, the medium with MTT was aspirated and this was followed by the addition of 100 lL of DMSO to dissolve the insoluble formazan. The plates were then shaken for 10 min. The absorbance of the formazan solution was read at 550 nm and the percentage of cell viability is calculated using the formula: For analysis of the results, 50 % inhibitory concentration (IC 50 ) was determined from the dose-response cytotoxic curves.
Antioxidant assays
Ferric thiocyanate (FTC) method
A screw-cap vial (/ 38 9 75 mm) containing a mixture of 2 mg of sample in 4 mL of 99.5 % ethanol, 4.1 mL of 2.51 % linoleic acid in 99.5 % ethanol, 8.0 mL of 0.02 M phosphate buffer (pH 7.0) and 3.9 mL of water was placed in an oven at 40°C in the dark (Kikuzaki and Nakatani, 1993) . 0.1 mL of this mixture in a test tube (/ 1.5 9 14.5 cm), 9.7 mL of 75 % (v/v) ethanol, 0.1 mL 30 % ammonium thiocyanate and finally, 0.1 mL of 2 9 10 -2 M ferrous chloride in 3.5 % hydrochloric acid were added to the reaction mixture. Three minutes after the addition of ferrous chloride, the absorbance was measured at 500 nm. This step was repeated every 24 h until 1 day after the control reached its maximum absorbance value.
Thiobarbituric acid (TBA) method
The samples prepared for FTC method were used for this assay. To 1 mL of 20 % aqueous trichloroacetic acid and 2 mL of 0.67 % aqueous thiobarbituric acid , 2 mL of the sample solution in a 10 mL centrifuge tube was added. The mixture was placed in a boiling water bath for 10 min. After cooling, it was centrifuged at 3,000 rpm for 30 min. Absorbance of the supernatant was measured at 532 nm. Antioxidant activity was based on the absorbance of the final day of FTC assay.
All the assays were carried out in triplicate and the readings were averaged.
Physicochemical calculations
Evaluation on the lipophilicity, solubility, polar surface area and other 'rule-of-five' parameters on the anthraquinones was performed using the online tools Molsinspiration and ALOGPS2.1 (Tetko et al., 2005; Veber et al., 2002) .
